Chronic central serous chorioretinopathy

Search with Google Search with Bing
Information
Disease name
Chronic central serous chorioretinopathy
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00211393 Completed Phase 2 A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole May 2005 April 2008
NCT00211445 Completed Phase 2 Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC) July 2002 January 2006
NCT00489840 Completed Phase 1/Phase 2 Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate May 2007
NCT01325181 Completed Phase 1/Phase 2 Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy July 2009 September 2012
NCT01434095 Completed N/A Microperimetric Evaluation After Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy October 2008 July 2010
NCT01797861 Completed Phase 4 Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy December 2013 May 2017
NCT02462499 Completed Phase 4 Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population June 2014 September 2016
NCT04224831 Completed N/A Treatment of Chronic Central Serous Chorioretinopathy Via Electromagnetic Stimulation and Platelet- Rich Plasma December 1, 2018 January 1, 2020
NCT05633576 Recruiting Phase 3 Steroid Eye Drops in Chronic Central Serous Chorioretinopathy February 19, 2023 July 19, 2025
NCT03079141 Unknown status Phase 4 Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous Chorioretinopathy February 20, 2017 August 2021
NCT02799992 Unknown status N/A Pseudo-PDT in Central Serous Chorioretinopathy June 2016 September 2016
MedGen concept unique identifier (MedGen Concept name)
C0730314
MedGen unique identifier (MedGen Concept name)
676513